APA (7th ed.) Citation

Culver, K., Seo, J., Trapali, M., Clarke, H., Whitty, J., Sethi, A., . . . Danes, C. (2025). 2033eP Exploring diversity in patient and caregiver treatment preferences for tyrosine kinase inhibitors (TKIs) in stage 4 ALK+ non-small cell lung cancer (NSCLC). Annals of Oncology, 36, S1155. https://doi.org/10.1016/j.annonc.2025.08.2655

Chicago Style (17th ed.) Citation

Culver, K.W, J. Seo, M. Trapali, H. Clarke, J. Whitty, A. Sethi, D. Cherepanov, S. Farmen, and C.G Danes. "2033eP Exploring Diversity in Patient and Caregiver Treatment Preferences for Tyrosine Kinase Inhibitors (TKIs) in Stage 4 ALK+ Non-small Cell Lung Cancer (NSCLC)." Annals of Oncology 36 (2025): S1155. https://doi.org/10.1016/j.annonc.2025.08.2655.

MLA (9th ed.) Citation

Culver, K.W, et al. "2033eP Exploring Diversity in Patient and Caregiver Treatment Preferences for Tyrosine Kinase Inhibitors (TKIs) in Stage 4 ALK+ Non-small Cell Lung Cancer (NSCLC)." Annals of Oncology, vol. 36, 2025, p. S1155, https://doi.org/10.1016/j.annonc.2025.08.2655.